And while it's true that the isoflavones in soy can weakly mimic estrogen, he added, they also seem to have anticancer, anti-inflammatory and antioxidant properties.
At a time when it is hard to raise new capital, the firm has decided to concentrate on anticancer therapies that, it hopes, are nearer to being commercial propositions than the stem-cell study is.